The clinical presentation of acne vulgaris in darker-skinned individuals differs in many ways from the white population, including some specific exacerbating factors that are due to cultural skin and hair-care practices.
The tetracycline-derived antibiotic sarecycline from Allergan plc and Paratek Pharmaceuticals Inc. for the treatment of moderate-to-severe acne has been found effective and safe, according to the results of two phase 3 trials.
This month, our clinical considerations include articles on the role of the microbe in acne, data around a topical agent to treat tinea pedis, and insights on sebum interacts with airborne pollution.
The difference between acne and healthy skin is largely dependent on the balance of the skin microbiota, according to study results.
A new study finds that use of dual laser therapy alone in skin types V and VI achieves excellent results with an exceptional side-effect profile.
Application of a topical photoparticle immediately before non-ablative 810 nm diode laser treatment for acne resulted in a statistically significant reduction from baseline in inflammatory acne counts on the back, according to a small feasibility study.
Hormonal therapies are an effective strategy to improve acne in women but some of these treatments, including birth control pills, are not commonly prescribed.
As part of its updated guidelines for the treatment of acne published early last year, the American Academy of Dermatology included new recommendations for the use of oral isotretinoin.
Dermatologists should turn to oral antibiotics for treating acne when topical medications have failed or are too irritating.
Combination therapies are under used; the role of diet, while controversial, may be beneficial; and, cosmeceuticals may remedy mild-to-moderate acne. Read more on acne treatment guidelines.